EGFR and glioblastoma: From a histological point of view, GBM presents with microvascular proliferation and necrosis and key molecular alteration such as the mutation of the telomerase reverse transcriptase (TERT) promoter, the amplification of EGFR (epidermal growth factor receptor), and the combined gain of the entire chromosome 7 and loss of whole chromosome 10 [1].